NL
DE
About
We develop, implement, and test new MR imaging and spectroscopy technology at clinical and ultra-high magnetic field MR scanners to improve fundamental understanding, diagnosis, and treatment response in cancer.
Aims
- Search for quantitative biomarkers with advanced MRI methods for improved diagnosis, staging, and assessment of aggressiveness of localized prostate cancer (extrapolation to other cancers)
- Development and evaluation of advanced MRI techniques for advanced (oligometastatic and castrate-resistant) prostate cancer
- Development and validation of nanoparticle-enhanced MRI in prostate, rectal, H&N, and upper abdominal cancers.
- Implementation of 3D motion-incorporating MRI in the abdomen (quantitative T2*, water/fat, T1)
